Faculty
Chris HOLSINGER
Stanford University

 

 

Dr. Chris Holsinger is Professor and Chief of Head and Neck Surgery at Stanford University.

His research focuses on surgical innovation and clinical trials. He has worked for over a decade on cooperative group clinical trials, leading surgical credentialing for RTOG920 and ECOG3311. In 2019, he published the results of an investigative device exemption clinical study to evaluate the safety and efficacy of a next-generation robotic surgical system for head and neck cancer.

His interests extend beyond robotics, however, and include new technologies for augmenting the vision of surgeons and incorporating computer vision and deep learning into routine surgical practice. Dr Holsinger’s research group aims to deliver these advantages to patients and their surgeons by providing real-time intelligence about surgical anatomy that extends beyond human vision.

Dr. Holsinger received his medical degree from Vanderbilt School of Medicine, completed his internship and residency at Baylor College of Medicine and his Fellowship in head and neck surgical oncology at The University of Texas M. D. Anderson Cancer Center. In 2003, he was awarded Fulbright Scholarship to study surgery at the University of Paris with Professor Ollivier Laccourreye and with Professor Wolfgang Steiner at the Georg-August University in Göttingen.

From 2001-2013, Dr. Holsinger worked at the Department of Head and Neck Surgery at the University of Texas M.D. Anderson Cancer Center where he co-founded and led the Program in Minimally Invasive Technology in Oncologic Surgery as the Laser Safety Committee.

In 2013, Dr. Holsinger moved to Stanford University, where at the Cancer Center led H&N Multidisciplinary Cancer Care Clinical Program for the next 5 years. Board-certified by the American Board of Otolaryngology, Dr. Holsinger is a member of numerous societies including the American College of Surgeons, American Head and Neck Society, the American Thyroid Association, and the American Society of Clinical Oncology.